CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit
Jeff Galvin, CEO of American Gene Technologies® provided testimony in a Senate Hearing on March 8, 2016 in support of Maryland’s Biotechnology Investment Incentive Tax Credit. His goal? To alter the definition of “qualified Maryland biotechnology company” so that an active business may claim the biotechnology tax credit – empowering gene therapy startups in the state of Maryland.